InvestorsHub Logo
Followers 2733
Posts 55279
Boards Moderated 4
Alias Born 08/10/2012

Re: None

Monday, 04/24/2017 11:15:03 PM

Monday, April 24, 2017 11:15:03 PM

Post# of 8351
$ETST To gain an understanding of the upside potential, investors can look at AXIM Biotech (OTCQB: AXIM) trading at $12, which commands a nearly $630 million market cap on trailing 12-month revenue of just over $50,000.

ETST, with trailing 12-month revenue of $430,000, closed today at a market cap of just $44 million.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ETST News